R. Ruhela

Potential of metabolomics in preclinical and clinical drug development

B. Kumar, A. Prakash, R. Ruhela, 2014, Pharmacological reports : PR.

Congenital malformation and autism spectrum disorder: Insight from a rat model of autism spectrum disorder

A. Prakash, R. Ruhela, B. Medhi, 2017, Indian journal of pharmacology.

Therapeutic Potential of Withania somnifera in CNS Disorders: A Neuropharmacological Review

R. Ruhela, B. Medhi, Shringika Soni, 2016 .

An urgent need for experimental animal model of autism in drug development

Bikash Medhi, Ajay Prakash, Rakesh K Ruhela, 2015, Annals of neurosciences.

Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective.

R. Ruhela, B. Medhi, Shringika Soni, 2016, Advanced pharmaceutical bulletin.

Terlipressin-induced Peripheral Ischemic Gangrene in a Diabetic Patient

R. Ruhela, B. Medhi, P. Sarma, 2017, Journal of pharmacology & pharmacotherapeutics.

Negative geotaxis: An early age behavioral hallmark to VPA rat model of autism

A. Prakash, R. Ruhela, B. Medhi, 2019, Annals of neurosciences.

Terlipressin-Induced Ischemic Complications: A Systematic Review of Published Case Reports

R. Ruhela, B. Medhi, P. Sarma, 2018 .